Clinical Trials Browser

Phase 2 × Unknown × Leukemia, B-Cell × Clear all

NCT03598179 2019-08-07

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell